HealthCare Global Enterprises Limited (HCG), a leading cancer care provider, has announced the completion of its acquisition of a 51% equity stake in Vizag Hospital and Cancer Research Centre Private Limited (Vizag Hospital). The acquisition was finalized following the signing of the Share Purchase Agreement (SPA) and Shareholders’ Agreement (SHA) on June 28, 2024, with amendments executed on October 1, 2024.
This acquisition, which was initially approved by the Board of Directors of HCG on July 2, 2024, aligns with the company’s expansion strategy in the healthcare sector, particularly in specialized cancer care.
The transaction was carried out in accordance with the terms agreed upon by HCG, Vizag Hospital, and its selling shareholders. The details regarding the SPA and SHA had been previously communicated to the stock exchanges, with no further disclosures required as per SEBI regulations.
This acquisition strengthens HCG’s presence in the cancer care landscape, enhancing its capacity to serve more patients with cutting-edge treatments and facilities.
